Maria Helane Costa Gurgel Castelo

ORCID: 0000-0003-3816-5612
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Lipoproteins and Cardiovascular Health
  • Lipid metabolism and disorders
  • Growth Hormone and Insulin-like Growth Factors
  • Nuclear Structure and Function
  • Thyroid Disorders and Treatments
  • Metabolism, Diabetes, and Cancer
  • Healthcare Regulation
  • Pituitary Gland Disorders and Treatments
  • Public Health in Brazil
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Mitochondrial Function and Pathology
  • Diabetes and associated disorders
  • SARS-CoV-2 and COVID-19 Research
  • Cardiovascular Effects of Exercise
  • Academic Research in Diverse Fields
  • HIV-related health complications and treatments
  • Cancer, Lipids, and Metabolism
  • Cardiovascular Function and Risk Factors
  • Diabetes Management and Research
  • Science and Education Research
  • PARP inhibition in cancer therapy
  • Thyroid Cancer Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Caveolin-1 and cellular processes

Hospital Universitário Walter Cantídio
2008-2024

Universidade Federal do Ceará
2008-2024

Unichristus
2020-2024

DASA (Brazil)
2020-2024

Insper
2024

Universidade de Fortaleza
2023-2024

Universidade de São Paulo
2017-2022

Hospital São Paulo
2017

Universidade Estadual de Campinas (UNICAMP)
2016-2017

Sociedade Brasileira de Oncologia Clínica
2017

Lipids are central in the development of cardiovascular disease, and present study aimed to characterize variation lipid profiles across different countries improve understanding risk opportunities for risk-reducing interventions.

10.1093/eurheartj/ehad371 article EN cc-by-nc European Heart Journal 2023-07-01
Erich Gnaiger Eleonor Aasander Frostner Norwahidah Abdul Karim Nada A. Abumrad Darío Acuña‐Castroviejo and 95 more Reginald Adiele Bumsoo Ahn Mayke Bezerra Alencar Sameh S. Ali Lesley A. Alton Marco Túlio Santana Alves Francesca Amati Nívea Dias Amoêdo Ioanna Andreadou Marc Arago Cenk Aral Odeta Arandarčikaitė Anne‐Sophie Armand Thierry Arnould Vlad Florian Avram Damian M. Bailey Sudip Bajpeyi Martina Bajzíková Barbara M. Bakker Jonathan Barlow A Banni a Yasseen Basma Ana Carolina Bastos Sant'Anna Silva Philip M. Batterson Maurizio Battino Jason N. Bazil Daniel Beard Piotr Bednarczyk Fiona Bello Dorit Ben‐Shachar Andreas Bergdahl Rolf K. Berge Lisa Bergmeister Paolo Bernardi Michael V. Berridge Stefano Bettinazzi David J. Bishop Pierre Blier Dan Filip Blindheim Neoma T. Boardman Hans Erik Boetker Sabine Borchard Mihály Boros Elisabet Børsheim Vilma Borutaite Javier Botella Frédéric Bouillaud Jamal Bouitbir Robert Boushel Josh Bovard Sophie Breton David Brown Guy J. Brown Robert N. Brown Joseph T. Brozinick Garry R. Buettner Johannes Burtscher Elisa Calabria José A. L. Calbet Enrico Calzia Daniel E. Cannon Maria Cano Sanchez Claudio A. Álvarez Daniele A. Cardinale Luiza H.D. Cardoso Eugénia Carvalho Marta Casado Pinna Samantha Cassar Maria Helane Costa Gurgel Castelo Laura Castro João Paulo Cavalcanti‐de‐Albuquerque Zuzana Červinková Béatrice Chabi Lisa Chakrabarti Sasanka Chakrabarti Bhagirath Chaurasia Qi Chen Adam J. Chicco Christos Chinopoulos Subir Roy Chowdhury Beáta Čižmárová Emilio Clementi Paul M. Coen Bruce S. Cohen Robert Coker Anne Collin Mt Coughlan Luís Crisóstomo Norma Dahdah Louise T. Dalgaard Maija Dambrova Tereza Daňhelovská Charles Darveau Anibh M. Das Ranjan Dash

10.26124/mitofit:190001.v6 preprint EN other-oa 2025-01-27

Justificativas A revisao da necessidade do jejum para determinacao perfil lipidico (colesterol total, LDL-C, HDL-C, nao-HDL-C e triglicerides [TG]) baseia-se nas seguintes justificativas: […] Posicionamento sobre a Flexibilizacao Jejum o Perfil Lipidico

10.5935/abc.20170039 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2017-01-01

Introdução A hipercolesterolemia familiar (HF) é uma causa genética comum de doença coronariana prematura, especialmente infarto do miocárdio, devido à exposição ao longo da vida a concentrações elevadas colesterol lipoproteína baixa densidade (LDL-c). Caracteriza-se por ser forma grave dislipidemia base genética, em que aproximadamente 85% dos homens e 50% das mulheres podem ter um evento coronariano antes completar os 65 anos idade, se não tratados adequadamente. HF considerada [...]

10.36660/abc.20210788 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2021-09-27

Sitosterolemia is a rare autosomal recessive disorder caused by homozygous or compound heterozygous variants in ABCG5/ABCG8. The disease characterized increased plasma plant sterols. Small case series suggest that patients with sitosterolemia have wide phenotypic heterogeneity great variability on either cholesterol levels development of atherosclerotic cardiovascular disease. present study aims to characterize the prevalence and clinical features participating familial hypercholesterolemia...

10.1161/circgen.121.003390 article EN Circulation Genomic and Precision Medicine 2022-05-12
Erich Gnaiger Eleonor Aasander Frostner Norwahidah Abdul Karim E. Abdelrahman Nada A. Abumrad and 95 more Darío Acuña‐Castroviejo Reginald Adiele Bumsoo Ahn Mayke Bezerra Alencar Sameh S. Ali Ángeles Almeida Lesley A. Alton Marco Túlio Santana Alves Francesca Amati Nívea Dias Amoêdo Ricardo Amorim Ethan Anderson Ioanna Andreadou Diana Antunes Marc Arago Cenk Aral Odeta Arandarčikaitė Christian Arias‐Reyes Anne‐Sophie Armand Thierry Arnould Vlad Florian Avram Christopher L. Axelrod Aïda Bairam Damian M. Bailey Sudip Bajpeyi Martina Bajzíková Barbara M. Bakker Jonathan Barlow Tora Bardal A Banni Ana Carolina Bastos Sant'Anna Silva Philip M. Batterson Maurizio Battino Jason N. Bazil Daniel Beard Jorge Beleza Piotr Bednarczyk Fiona Bello Dorit Ben‐Shachar Jose Freitas Bento Guida Andreas Bergdahl Rolf K. Berge Lisa Bergmeister Paolo Bernardi Michael V. Berridge Stefano Bettinazzi David J. Bishop Pierre Blier Dan Filip Blindheim Neoma T. Boardman Hans Erik Boetker Sabine Borchard Mihály Boros Elisabet Børsheim Consuelo Borrás Vilma Borutaite Javier Botella Frédéric Bouillaud Jamal Bouitbir Robert Boushel Josh Bovard Roberto Bravo Sophie Breton David C. Brown Guy C. Brown Robert N. Brown Joseph T. Brozinick Garry R. Buettner Johannes Burtscher Matilde Bustos Elisa Calabria José A. L. Calbet Enrico Calzia Daniel E. Cannon Maria Cano Sanchez Carles Canto Alvarez Daniele A. Cardinale Luiza H.D. Cardoso Eugénia Carvalho Marta Casado Pinna Samantha Cassar Maria Helane Costa Gurgel Castelo Roger F. Castilho João Paulo Cavalcanti‐de‐Albuquerque Cristiane Cecatto Murat Celen Zuzana Červinková Béatrice Chabi Lisa Chakrabarti Sasanka Chakrabarti Bhagirath Chaurasia Quan Chen Adam J. Chicco Christos Chinopoulos Subir Roy Chowdhury

10.26124/bec:2020-0001.v1 article EN 2020-01-01

Metabolic abnormalities in congenital generalized lipodystrophy (CGL) are associated with microvascular complications. However, the evaluation of different types neuropathy these patients, including commitment cardiovascular autonomic modulation, is scarce. The objective present study was to determine prevalence (CAN) patients CGL compared individuals type 1 diabetes and healthy subjects. Ten CGL, 20 subjects were included study. Controls paired 1:2 for age, gender, BMI pubertal stage. Heart...

10.1186/s12872-017-0738-4 article EN cc-by BMC Cardiovascular Disorders 2018-01-12

Carta de Apresentação A síndrome da quilomicronemia familiar (SQF) é uma forma grave dislipidemia e compreende um conjunto múltiplos sinais sintomas causados pela deficiência enzima lipoproteína lipase (LPL) ou seus cofatores, comprometendo o metabolismo triglicérides. Apresenta modo herança autossômico recessivo acomete cerca 1 a 2 pessoas por milhão indivíduos, mas pode ser mais frequente quando existe consanguinidade. Existe grande desconhecimento sobre essa condição e, esse motivo, [...]

10.36660/abc.20230203 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2023-04-01

Congenital generalized lipodystrophy (CGL) is a rare disorder characterized by the absence of subcutaneous adipose tissue, severe insulin resistance, diabetes mellitus, and cardiovascular complications, including cardiac autonomic neuropathy (CAN), left ventricular hypertrophy (LVH), atherosclerosis. The present study aimed to access association between CAN parameters abnormalities in CGL patients. A cross-sectional was conducted with 10 patients 20 healthy controls matched for age, sex,...

10.1186/s13098-019-0444-8 article EN cc-by Diabetology & Metabolic Syndrome 2019-07-01

OBJECTIVE: To report the clinical and molecular aspects of a patient with diagnosis Resistance to Thyroid Hormone (RTH) harboring E449X mutation associated autoimmune thyroid disease severe neuropsychomotor retardation. METHODS: We present case including laboratory findings, analysis Brazilian RTH. RESULTS: A 23-year old male presented hyperactivity disorder, attention deficit, delayed development, goiter. Since age 1 year 8 months, his mother had sought medical care for her son...

10.1590/s0004-27302008000800002 article EN Arquivos Brasileiros de Endocrinologia & Metabologia 2008-11-01

Objective This study aimed to determine the thyroid-stimulating hormone (TSH) reference interval (RI) and assess influence of use thyroid ultrasonography (TUS) on individual selection from a healthy adult population in Fortaleza, Brazil. Subjects methods cross-sectional recruited patients (N = 272; age 18-50 years) with normal function (NTF) placed them three groups according their test results: NTF (n all participants), TUS 170; participants who underwent US), RI 124; individuals TSH...

10.20945/2359-3997000000264 article EN Archives of Endocrinology and Metabolism 2020-07-17

Previous studies suggest intestinal dysbiosis is associated with metabolic diseases. However, the causal relationship between them not fully elucidated. Gut microbiota evaluation of patients congenital generalized lipodystrophy (CGL), a disease characterized by absence subcutaneous adipose tissue, insulin resistance, and diabetes since first years life, could provide insights into these relationships.A cross-sectional study was conducted CGL (n = 17) healthy individuals 17). The gut...

10.1186/s13098-022-00908-8 article EN cc-by Diabetology & Metabolic Syndrome 2022-09-24

A premature myocardial infarction (PMI) is usually associated with a familial component. This study evaluated cardiovascular risk factors in first-degree relatives (FDR) of patients PMI not presenting the hypercholesterolemia phenotype. cross-sectional comprising FDR non-familial who suffered <45-years age matched for and sex individuals without family history disease. Subjects were presence metabolic syndrome its components, lifestyle, statin therapy, laboratory parameters. The sample was...

10.1186/s12944-017-0605-4 article EN cc-by Lipids in Health and Disease 2017-11-27

Hypertriglyceridemia (HTG) is a common dyslipidemia associated with an increased risk of cardiovascular disease and pancreatitis. It well stablished that the severe cases often present underlying genetic cause. In this study, we determined frequency variation spectrum genes involved in triglyceride metabolism series Brazilian patients HTG. A total 212 very high HTG, defined fasting triglycerides (TG) ≥ 880 mg/ dL, underwent multi-gene panel testing were included research. Germline...

10.1016/j.ymgmr.2024.101100 article EN cc-by-nc-nd Molecular Genetics and Metabolism Reports 2024-06-07

Abstract Background Fulminant purpura is a clinical syndrome characterized by purplish, ischemic-looking skin rash, commonly accompanied systemic symptoms ranging from acute febrile to septic shock. Due high lethality of possible infectious etiologies, immediate recognition and early initiation empirical antimicrobial therapy are crucial ensure better outcomes. Interdisciplinary collaboration among healthcare teams, disease specialists microbiologists essential accurate microbiological...

10.1093/clinchem/hvae106.279 article EN Clinical Chemistry 2024-10-01

Abstract Background Prolactin (PRL) exists in different forms human serum. The predominant form is monomeric PRL, the other include dimeric PRL and polymeric also known as macroprolactin, a biologically inactive form. Macroprolactin can be measured by almost all immunoassays for PRL. This may lead to misdiagnosis mismanagement of patients. Polyethylene glycol (PEG) precipitation most widely used method detecting generally employing cutoff 40% distinguish macroprolactinemia from true...

10.1093/clinchem/hvae106.070 article EN Clinical Chemistry 2024-10-01
Coming Soon ...